z-logo
open-access-imgOpen Access
Multitarget therapeutic strategies for Alzheimer’s disease
Author(s) -
Mostafa M.H. Ibrahim,
Moustafa T. Gabr
Publication year - 2019
Publication title -
neural regeneration research/neural regeneration research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.93
H-Index - 38
eISSN - 1876-7958
pISSN - 1673-5374
DOI - 10.4103/1673-5374.245463
Subject(s) - disease , neuroscience , huntington's disease , alzheimer's disease , medicine , cholinesterase , bioinformatics , computational biology , pharmacology , biology , pathology
Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neurodegenerative diseases has developed a pressing need to design multitarget-directed ligands to address the complementary pathways involved in these diseases. The major enzyme targets for development of therapeutics for Alzheimer's disease are cholinesterase and β-secretase enzymes. In this review, we discuss recent advances in profiling single target inhibitors based on these enzymes to multitarget-directed ligands as potential therapeutics for this devastating disease. In addition, therapeutics based on iron chelation strategy are discussed as well.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here